The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 6, 2007, Pages 725-728

  Lu, Meisong ^a   Xiao, Lan ^b   Li, Zhimin ^c   Hu, Jianli ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell apoptosis; Multidrug resistance; Ovarian carcinoma; P38 mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; GLYCOPROTEIN P; IMIDAZOLE DERIVATIVE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PACLITAXEL; PROTEIN P53; PYRIDINE DERIVATIVE;

APOPTOSIS; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FEMALE; HUMANS; IMIDAZOLES; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PACLITAXEL; PYRIDINES; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38849090837     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0628-6     Document Type: Article

References (10)

1. Park M T, Choi J A, Kim M J et al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8 and mitochondriamediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem, 2003,278:50624-50634
2. Fesik S W. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 2005,5(11):876-885
3. Xiong H Q. Molecular targeting therapy for pancreatic cancer. Cancer Chemother Pharmacol, 2004,54(Suppl 1):S69
4. English J M, Cobb M H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci, 2002,23(1):40-45
5. Lin J C, Chang S Y, Hsieh D S et al. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells. J Urol, 2005,174(5):2022-2026
6. Wada T, Penninger J M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 2004,23(16):2838-2849
7. Dent P, Yacoub A, Fisher P B et al. MAPK pathways in radiation responses. Oncogene, 2003,22(37):5885-5896
8. Habiro A, Tanno S, Koizumi K et al. Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun, 2004,316:71-78
9. Ricardo S P, Jose M R, Yoichi J et al. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on gerlotoxic stress by chemotherapeutic agents. Cancer Res, 2000,60:2464-2472
10. Kohno M, Pouyssegur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res, 2003,5:219-2248